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TO THE EDITOR
Cholinergic urticaria (CholU) is a rare
condition that is clinically characterized
by pinpoint-sized, highly pruritic wheals.
CholU is occasionally associated with
depressed sweating, as reported under
the name of hypohidrosis (incomplete
lack of sweating) or anhidrosis (complete
lack of sweating) (CholU with hypohi-
drosis or anhidrosis (CUHA) (Bito et al.,
2012)). We have recently shown that
CUHA patients develop wheals
exclusively on the hypohidrotic area
where the expression of cholinergic
receptor M3 (CHRM3) is incompletely
decreased in sweat gland epithelial cells
and mast cells, whereas the patients did
not exhibit wheals in the anhidrotic area
where CHRM3 expression is completely
absent (Sawada et al., 2010).
Acetylcholine esterase (AchE) is a
processing enzyme of acetylcholine,
and disordered AchE might contribute
to the pathogenesis of CholU (Magnus
and Thompson, 1956). However, the
mechanism underlying the reduction
of AchE release in CholU remains
unelucidated. Moreover, there have
been a considerable number of reports
demonstrating that T lymphocytes
infiltrate around eccrine glands in
CholU patients and that the systemic
corticosteroid therapy improves
sweating, as well as urticaria (Nakazato
et al., 2004). We therefore investigated
the eccrine gland expression of AchE
and CHRM3 and characterized skin-
infiltrating lymphocytes/mast cells and
attracting chemokines.
Enrolled in this study were nine
CUHA patients, three CholU patients,
and five healthy controls (Table 1).
CUHA and CholU were diagnosed on
the basis of typical episodes of small
pinpoint wheals following exercise and
sweating (Black et al., 1996), and were
confirmed by our provocation test
showing the development of numerous
small wheals after exercise. Sweating
was evaluated with starch-iodine test.
The study design was approved by the
review board of University of Occu-
pational and Environmental Health
and was conducted according to the
Declaration of Helsinki guidelines.
Measurements in this study were
performed after written informed
consent had been obtained from these
patients.
Skin biopsy specimens were taken
from the patients and healthy control
subjects. Significantly higher numbers
of lymphocytes (Figure 1a) and mast
cells (Figure 1b) infiltrated around
eccrine glands in CUHA patients
than in controls and CholU patients.
The lymphocytes consisted of a mixture
of CD4þ and CD8þ T cells and a
mixture of CXCR3þ (mostly Th1 cells)
and CCR4þ T cells (mostly Th2 cells)
in all cases. The deparaffinized sec
tions were immunohistochemically
stained with anti-AchE, anti-CHRM3,
anti-CXCL9/MIG, anti-CXCR10/IP-10, anti-
CXCL11/I-TAC, anti-CCL2/MCP-1, anti-
CCL3/MIP-1a, anti-CCL5/RANTES,
anti-CCL17/TARC, and anti-CCL22/
MDC antibodies. Digitalized specimens
were exported to JPG files by the NDP
view software (Hamamatsu Photonics,
Hamamatsu, Japan), and the staining
intensity was expressed as ‘‘red density’’
(RD) (Hino et al., 2010; Sawada et al.,
2010). The expression levels of CCL2/
MCP-1, CCL5/RANTES, and CCL17/
TARC were highest in CUHA andAccepted article preview online 7 June 2013; published online 11 July 2013
Abbreviations: AchE, acetylcholine esterase; AD, atopic dermatitis; CHRM3, cholinergic receptor M3;
CholU, cholinergic urticaria; CUHA, cholinergic urticaria with hypohidrosis or anhidrosis; RD, red density
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moderate in CholU (Figure 1c). The
AchE and CHRM3 expressions were
lowest in CUHA and moderately abro-
gated in CholU patients (Figure 1d). The
expression levels in all patients were
assessed by RD with statistical signifi-
cance (Supplementary Figure S1 online).
Real-time PCR analyses of relative
mRNA levels of these cytokines were
performed as described previously
(Sawada et al., 2010). The mRNA expres-
sions of CCL2/MCP-1, CCL5/RANTES,
and CCL17/TARC were elevated signifi-
cantly in CUHA (Figure 1e), whereas
AchE and CHRM3 were decreased in
CUHA (Figure 1f), supporting the immu-
nohistochemical data. Moreover, statisti-
cal analyses revealed that the expression
levels of CCL2/MCP-1, CCL5/RANTES,
and CCL17/TARC positively correlated
with the number of infiltrating lympho-
cytes and mast cells, and AchE and
CHRM3 inversely correlated with them
(Supplementary Figure S2 online), sug-
gesting that the T cells exert a down-
modulatory effect on the AchE and
CHRM3 expressions.
The major finding of this study is the
decreased expressions of AChE and
CHRM3 in eccrine gland epithelial cells
of CUHA patients. In all patients, the
AchE and CHRM3 expressions were
decreased concomitantly in association
with the lymphocytic inflammation.
This suggests that acetylcholine is
incompletely degraded owing to paucity
of AchE. Moreover, the overproduced
acetylcholine is incapable of binding to
CHRM3, whose expression is reduced
in eccrine glands. Acetylcholine is then
considered to overflow to adjacent mast
cells, which are stimulated to degranu-
late by acetylcholine (Takahashi et al.,
1992). Thus, wheals, hypohidrosis, and
pain seem to result from the low
expression levels of AchE and CHRM3.
It has been known that lymphocytes
infiltrate around eccrine glands in
CUHA (Sawada et al., 2010). Our
study showed the inverse correlation
between the number of infiltrating
lymphocytes and the expression levels
of AchE and CHRM3 in eccrine glands.
As the expression levels of CCL2/
MCP-1, CCL5/RANTES, and CCL17/
TARC were increased in the eccrine
gland epithelial cells of CUHA, it is
likely that T cells are attracted by these
chemokines and affect AChE and
CHRM3 expressions.
CholU is frequently associated with
atopic conditions, especially atopic der-
matitis (AD) (Takahagi et al., 2008),
suggesting that Th2-skewing condition
might be dominant in CUHA or CholU
patients. In a former review, 43% cases
of acquired idiopathic generalized
anhidrosis displayed elevated serum
IgE levels, suggesting an allergic
etiology in CUHA (Nakazato et al.,
2004). We compared the chemokine
expressions between AD and psoriasis
vulgaris. Without CUHA or CholU, AD
lesional skin expressed CCL2/MCP-1,
CCL5/RANTES, and CCL17/TARC at
remarkably higher levels than psoriatic
lesios and healthy control skin
(Supplementary Figure S3 online). His-
tologically, epidermal keratinocytes in
the urticarial skin of CUHA did not
show apoptotic, dyskeratotic cells as a
result of Tc1 attack of epidermal cells,
suggesting that infiltration of Tc1 is
minimal in CUHA. Instead, CD4þ and
CD8þ T-cell populations chemoat-
tracted by CCL2/MCP-1, CCL5/RANTES,
and CCL17/TARC might affect eccrine
gland epithelial cells to abrogate the
expression levels of AchE and CHRM3.
It appears that mast cells also infiltrate
around eccrine glands by virtue of
the chemokines and promote the urti-
carial condition. CCL2/ MCP-1, CCL5/
RANTES, and CCL17/TARC have been
shown as chemoattractants for mast
cells (Conti et al., 1997; Tsunemi
et al., 2006). Corticosteroid inhibits the
expressions of CCL2/MCP-1, CCL5/
RANTES, and CCL17/TARC (Pype
et al., 1999; Hoshino et al., 2005).
These findings also support the notion
that CCL2/MCP-1, CCL5/RANTES,
and CCL17/TARC have a crucial role
in CUHA and CholU patients. Our
study suggests that T cells infiltrating
around eccrine glands are a possible
pathogenetic trigger for CUHA.
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Table 1. Characteristics of patients with CUHA (patients 1–9) or CholU (patients 10–12)
Patient Age Sex Acetylcholine test1 Autologous serum skin test Autologous sweat skin test Accompany Pain
1 23 Male Weakly positive Negative Negative Hypohidrosis and anhidrosis þ
2 50 Male Weakly positive Negative Negative Hypohidrosis and anhidrosis þ
3 24 Male Weakly positive Negative Negative Hypohidrosis and anhidrosis þ
4 36 Male Weakly positive Negative Negative Hypohidrosis and anhidrosis þ
5 20 Male Weakly positive Negative Negative Hypohidrosis and anhidrosis þ
6 21 Male Weakly positive Negative Negative Hypohidrosis and anhidrosis þ
7 25 Male Weakly positive Negative Negative Hypohidrosis and anhidrosis þ
8 35 Male Weakly positive Negative Negative Hypohidrosis and anhidrosis þ
9 41 Female Weakly positive Negative Positive Hypohidrosis and anhidrosis, AD þ
10 29 Female Positive Negative Positive AD 
11 15 Male Positive Negative Negative — 
12 25 Male Positive Negative Negative — þ
Abbreviations: AD, atopic dermatitis; CholU, cholinergic urticaria; CUHA, cholinergic urticaria with hypohidrosis or anhidrosis.
1Acetylcholine test was performed on the hypohidrotic area in CUHA.
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Figure 1. Histopathological and immunohistochemical examination of lymphocytes and mast cells infiltrating around sweat glands, and the expression of
chemokines, acetylcholine esterase (AchE), and cholinergic receptor M3 (CHRM3) in eccrine glands. (a) The number of infiltrating lymphocytes around
eccrine glands in high-power field (HPF;  200). Bars¼mean±SD. (b) The number of mast cells around eccrine glands in HPF ( 200). Bars¼mean±SD.
(c) Representative immunohistochemical staining patterns of CCL2/MCP-1, CCL5/RANTES, and CCL17/TARC. (d) Representative immunohistochemical staining
patterns of AchE and CHRM3. (e) Relative mRNA levels of CCL2/MCP-1, CCL5/RANTES, and CCL17/TARC. (f) Relative mRNA levels of AchE and CHRM3.
CholU, cholinergic urticaria; CUHA, CholU with hypohidrosis or anhidrosis.
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Mouse Alopecia Areata and Heart Disease: Know Your
Mouse!
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TO THE EDITOR
The proceedings of a recent meeting on
alopecia areata (AA) (Bertolini et al.,
2012) summarized work using the
surgically induced C3H/HeJ mouse
model for AA (McElwee et al., 1998;
Wang et al., 2013), in which the investi-
gators found enlarged hearts in affected
mice, suggesting an association between
AA and cardiac findings. However, the
heart lesions described are a well-known
strain-specific disease not limited to C3H
substrains. These lesions have been
described by a number of names includ-
ing epicardial mineralization with fibrosis
and dystrophic cardiac calcinosis (Eaton
et al., 1978; Frith and Ward, 1988).
Crosses between C3H/HeJ and C57BL/6J
mice have identified four quantitative
trait loci (QTLs), designated as dystro-
phic cardiac calcinosis 1–4 (Dyscalc1–
4; Ivandic et al., 2001). Mapping to
mouse Chromosome 7 (Ivandic et al.,
1996), Dyscalc1 was subsequently
identified as being due to non-synony-
mous single-nucleotide polymorphisms
in the ATP-binding cassette, subfamily C
(CFTR/MRP), member 6 (Abcc6) gene
(Meng et al., 2007; Aherrahrou et al.,
2008). Mutations in the human ABCC6
gene and targeted mutations in the mouse
Abcc6 gene produce pseudoxanthoma
elasticum (PXE) (Gorgels et al., 2005;
Klement et al., 2005), a systemic meta-
bolic disease with cutaneous features
distinct from AA (Uitto et al., 2010).
In a massive histopathological screen-
ing of all organ systems in 31 inbred
strains of mice of both genders, dys-
trophic cardiac calcinosis was
diagnosed in eight strains (Berndt
et al., in preparation; Sundberg et al.,
2011). C3H/HeJ and A/J strains were
found to develop both heart lesions
(Chase et al., 2009) and AA (McElwee
et al., 1999) in the aging study, although
in both cases more mice with normal
skin had heart lesions than those with
AA (Table 1a). Three strains were found
to develop histologically confirmed AA
(MRL/MpJ, SJL/J, and SWR/J), but none of
these mice had any type of heart lesion.
No correlation was found in a retired
breeder study (Table 1b) (Berndt et al., in
preparation) or in a large mouse cross
(C3H/HeJ  C57BL/6J, C3B6F2;
Table 1c) generating F2 females for
identifying AA eQTLs. Heart lesions
varied in severity and location between
the strains (Berndt et al., in prepara-
tion). Genome-wide association map-
ping determined that none of the QTLs
for dystrophic cardiac calcinosis corre-
sponded to genomic regions identified
to determine AA.Accepted article preview online 17 June 2013; published online 18 July 2013
Abbreviations: AA, alopecia areata; Abcc6 (mouse gene), ABCC6 (human gene), ATP-binding cassette
subfamily C, member 6, gene; Dyscalc1–4, dystrophic cardiac calcinosis 1–4; PXE, pseudoxanthoma
elasticum; QTL, quantitative trait loci
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